Cargando…
Bacteriophage ZCSE2 is a Potent Antimicrobial against Salmonella enterica Serovars: Ultrastructure, Genomics and Efficacy
Developing novel antimicrobials capable of controlling multidrug-resistant bacterial pathogens is essential to restrict the use of antibiotics. Bacteriophages (phages) constitute a major resource that can be harnessed as an alternative to traditional antimicrobial therapies. Phage ZCSE2 was isolated...
Autores principales: | Mohamed, Ahmed, Taha, Omar, El-Sherif, Hesham M., Connerton, Phillippa L., Hooton, Steven P.T., Bassim, Nabil D., Connerton, Ian F., El-Shibiny, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232530/ https://www.ncbi.nlm.nih.gov/pubmed/32283768 http://dx.doi.org/10.3390/v12040424 |
Ejemplares similares
-
The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin
por: Abdelsattar, Abdallah S., et al.
Publicado: (2023) -
Bacteriophage ZCKP1: A Potential Treatment for Klebsiella pneumoniae Isolated From Diabetic Foot Patients
por: Taha, Omar A., et al.
Publicado: (2018) -
The Synergistic Effect of Biosynthesized Silver Nanoparticles and Phage ZCSE2 as a Novel Approach to Combat Multidrug-Resistant Salmonella enterica
por: Abdelsattar, Abdallah S., et al.
Publicado: (2021) -
Complete Genome Sequence of Salmonella enterica Serovar Typhimurium U288
por: Hooton, Steven P. T., et al.
Publicado: (2013) -
Campylobacter bacteriophage DA10: an excised temperate bacteriophage targeted by CRISPR-cas
por: Hooton, Steven, et al.
Publicado: (2020)